Detalhe da pesquisa
1.
Variant-specific IgA protects against Omicron infection.
J Infect Dis;
2023 Nov 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37996071
2.
Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters.
J Med Virol;
95(1): e28258, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36305052
3.
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial.
Clin Infect Dis;
75(12): 2088-2096, 2022 12 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35543372
4.
Design, Synthesis and Evaluation of New Indolylpyrimidylpiperazines for Gastrointestinal Cancer Therapy.
Molecules;
24(20)2019 Oct 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31614517
5.
Alpha-Ketoglutarate dietary supplementation to improve health in humans.
Trends Endocrinol Metab;
33(2): 136-146, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34952764
6.
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
Trials;
23(1): 498, 2022 Jun 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35710572
7.
Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant.
Lancet Reg Health West Pac;
33: 100732, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37125085